Tokyo, (ANTARA News/PRNewswire-AsiaNet) - Cognizant (Nasdaq: CTSH), a leading provider of global consulting, software, IT infrastructure and business process services today announced an alliance with CTC Laboratory Systems (CTCLS) to help Japanese pharmaceutical companies enhance efficiencies in drug discovery and development.
CTCLS, the subsidiary of one of the largest system integrators in Japan, ITOCHU Techno-Solutions Corporation (TSE: CTC), is a provider of IT solutions for the discovery and clinical phases of the pharmaceutical lifecycle.
The Company has deep capabilities in applications that support gene information analysis, good laboratory practice (for nonclinical studies), good clinical practice (for clinical studies), e-application and post-marketing surveillance.
CTCLS works with more than 20 of the Top 30 Japanese pharmaceutical companies and represents some of the leading informatics product vendors in that market.
"Our partnership with Cognizant will help us jointly address the pharmaceutical industry in Japan by leveraging the local insights of CTCLS and the global talent pool, domain depth and delivery best practices of Cognizant," said Hideki Negishi, president and CEO of CTCLS.
"The combined expertise of the two companies in delivering value to the top pharmaceutical companies globally and in Japan will help us address the pressure points of Japanese pharmaceutical companies in areas of discovery, clinical, manufacturing and commercial operations."
"We believe that our partnership with CTCLS will help us scale our Japanese operations, with a special emphasis on our pharmaceutical practice," said R Chandrasekaran, president and managing director, Cognizant.
"Our combined value proposition will help Japanese pharmaceutical companies to crunch the cycle time for discovery and clinical development, reduce overall cost of drug discovery, and innovatively transform the way they deliver healthcare."
About CTC Laboratory Systems
CTC Laboratory Systems (CTCLS) was established in 1989 with investments from Itochu Techno-Science (currently Itochu Techno-Solutions) and Itochu Corporation to provide IT solutions for the life sciences industry. CTCLS is today a 100 per cent subsidiary of Itochu Techno-Solutions Corporation.
As a system integrator that supports pharmaceutical R&D, CTCLS offers a series of services from information infrastructure to the sales, development, and support of application software. CTCLS's business is not limited to the provision of solutions to the R&D divisions of pharmaceutical, chemical, and food manufacturers, but also extends to highly valued comprehensive solutions, including marketing information systems.
About Cognizant
Cognizant (Nasdaq: CTSH) is a leading provider of information technology, consulting and business process outsourcing services. Cognizant's single-minded passion is to dedicate our global technology and innovation know-how, our industry expertise and worldwide resources to working together with clients to make their businesses stronger. With more than 35 global delivery centers and over 55,000 employees as of December 31, 2007, we combine a unique onsite/offshore delivery model infused by a distinct culture of customer satisfaction.
A member of the NASDAQ-100 Index and S&P 500 Index, Cognizant is a Forbes Global 2000 company and is ranked among the top information technology companies in BusinessWeek's Info Tech 100, Hot Growth and Top 50 Performers listings.
Visit us online at www.cognizant.com
About Cognizant's Healthcare and Life Sciences Practice
Cognizant's Healthcare and Life Sciences practice is committed to helping change billions of lives for the better by partnering with our customers to build solutions to healthcare challenges, continually improve the way they do business, set the pace in clinical development, strengthen their regulatory infrastructure, and increase competitiveness.
Consistently ranked among the Healthcare Informatics Top 100 list for the past three years, we work for 6 of the top 10 health plans in the U.S.A., 27 of the top 30 global pharmaceutical companies, 9 of the top 10 biotech companies, and 2 of the top 5 medical device companies.
With over 10,000 dedicated professionals including doctors, pharmacologists, physicians, biomedical engineers, pharmacists, biostatisticians, medical writers, and GxP consultants, we provide domain-aligned consulting, IT, business process and analytics solutions globally.
Forward-Looking Statements
This press release includes statements which may constitute forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, the accuracy of which are necessarily subject to risks, uncertainties, and assumptions as to future events that may not prove to be accurate. Factors that could cause actual results to differ materially from those expressed or implied include general economic conditions and the factors discussed in our most recent Form 10-K and other filings with the Securities and Exchange Commission. Cognizant undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.
SOURCE: Cognizant
CONTACT: Takeuchi, Tomoaki, 81-3-5404-8468, for Cognizant
Web site: http://www.cognizant.com
CTCLS, the subsidiary of one of the largest system integrators in Japan, ITOCHU Techno-Solutions Corporation (TSE: CTC), is a provider of IT solutions for the discovery and clinical phases of the pharmaceutical lifecycle.
The Company has deep capabilities in applications that support gene information analysis, good laboratory practice (for nonclinical studies), good clinical practice (for clinical studies), e-application and post-marketing surveillance.
CTCLS works with more than 20 of the Top 30 Japanese pharmaceutical companies and represents some of the leading informatics product vendors in that market.
"Our partnership with Cognizant will help us jointly address the pharmaceutical industry in Japan by leveraging the local insights of CTCLS and the global talent pool, domain depth and delivery best practices of Cognizant," said Hideki Negishi, president and CEO of CTCLS.
"The combined expertise of the two companies in delivering value to the top pharmaceutical companies globally and in Japan will help us address the pressure points of Japanese pharmaceutical companies in areas of discovery, clinical, manufacturing and commercial operations."
"We believe that our partnership with CTCLS will help us scale our Japanese operations, with a special emphasis on our pharmaceutical practice," said R Chandrasekaran, president and managing director, Cognizant.
"Our combined value proposition will help Japanese pharmaceutical companies to crunch the cycle time for discovery and clinical development, reduce overall cost of drug discovery, and innovatively transform the way they deliver healthcare."
About CTC Laboratory Systems
CTC Laboratory Systems (CTCLS) was established in 1989 with investments from Itochu Techno-Science (currently Itochu Techno-Solutions) and Itochu Corporation to provide IT solutions for the life sciences industry. CTCLS is today a 100 per cent subsidiary of Itochu Techno-Solutions Corporation.
As a system integrator that supports pharmaceutical R&D, CTCLS offers a series of services from information infrastructure to the sales, development, and support of application software. CTCLS's business is not limited to the provision of solutions to the R&D divisions of pharmaceutical, chemical, and food manufacturers, but also extends to highly valued comprehensive solutions, including marketing information systems.
About Cognizant
Cognizant (Nasdaq: CTSH) is a leading provider of information technology, consulting and business process outsourcing services. Cognizant's single-minded passion is to dedicate our global technology and innovation know-how, our industry expertise and worldwide resources to working together with clients to make their businesses stronger. With more than 35 global delivery centers and over 55,000 employees as of December 31, 2007, we combine a unique onsite/offshore delivery model infused by a distinct culture of customer satisfaction.
A member of the NASDAQ-100 Index and S&P 500 Index, Cognizant is a Forbes Global 2000 company and is ranked among the top information technology companies in BusinessWeek's Info Tech 100, Hot Growth and Top 50 Performers listings.
Visit us online at www.cognizant.com
About Cognizant's Healthcare and Life Sciences Practice
Cognizant's Healthcare and Life Sciences practice is committed to helping change billions of lives for the better by partnering with our customers to build solutions to healthcare challenges, continually improve the way they do business, set the pace in clinical development, strengthen their regulatory infrastructure, and increase competitiveness.
Consistently ranked among the Healthcare Informatics Top 100 list for the past three years, we work for 6 of the top 10 health plans in the U.S.A., 27 of the top 30 global pharmaceutical companies, 9 of the top 10 biotech companies, and 2 of the top 5 medical device companies.
With over 10,000 dedicated professionals including doctors, pharmacologists, physicians, biomedical engineers, pharmacists, biostatisticians, medical writers, and GxP consultants, we provide domain-aligned consulting, IT, business process and analytics solutions globally.
Forward-Looking Statements
This press release includes statements which may constitute forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, the accuracy of which are necessarily subject to risks, uncertainties, and assumptions as to future events that may not prove to be accurate. Factors that could cause actual results to differ materially from those expressed or implied include general economic conditions and the factors discussed in our most recent Form 10-K and other filings with the Securities and Exchange Commission. Cognizant undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.
SOURCE: Cognizant
CONTACT: Takeuchi, Tomoaki, 81-3-5404-8468, for Cognizant
Web site: http://www.cognizant.com
COPYRIGHT © 2008
